跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SU3327
首页
药物
SU3327
SU3327
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of C-JUN N-terminal kinase inhibitor SU3327
申请人: CHEN HONGLIANG
优先权: 2020
CN
4 件公开
Application of SU3327 in preparation of anti-vibrio parahaemolyticus medicine
申请人: UNIV CHINA AGRICULTURAL
优先权: 2024
CN
Clathrate compound of SU3327 and cyclodextrin derivative, preparation and preparation method of clathrate compound
申请人: UNIV CHINA AGRICULTURAL
优先权: 2023
CN
USE OF SU3327 IN PREPARING DRUG FOR ENHANCING ANTI-BACTERIAL-INFECTION EFFICACY OF POLYMYXIN
申请人: XIAMEN HANLIXIN PHARMACEUTICAL CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
USE OF SU3327 IN PREPARATION OF MEDICAMENT FOR REDUCING CYTOTOXICITY AND NEPHROTOXICITY OF POLYMYXIN
申请人: XIAMEN HANLIXIN PHARMACEUTICAL CO LTD
优先权: 2023
CN
EP
US
WO
4 件公开
Antibacterial composition containing SU3327 and tannic acid as well as preparation method and application of antibacterial composition
申请人: SANYA RESEARCH INSTITUTE CHINA AGRICULTURAL UNIV
优先权: 2025
CN
一种宠物外用SU3327喷剂及其制备方法和应用
申请人: 中国农业大学
优先权: 2024
CN
Application of C-JUN N-terminal kinase inhibitor SU3327 in preparation of medicine for treating bacterial respiratory tract infection
申请人: UNIV CHINA AGRICULTURAL
优先权: 2024
CN
药物
反馈